PHILADELPHIA, Pennsylvania, Aug. 4 -- Molecular Cancer Therapeutics, a journal from the American Association for Cancer Research that publishes focuses on discovery and preclinical developments of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, mechanisms of drug resistance, biomarkers of drug response, novel models and technologies and drug toxicity mechanisms, posted research articles on the following topics in its July 2023 editi . . .

Click here for more information about our products